Clinical Trials List
2017-08-28 - 2019-10-02
Phase III
Terminated3
ICD-10E11
Type 2 diabetes mellitus
ICD-9250.00
Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林怡君 Division of Endocrinology
The Actual Total Number of Participants Enrolled
28 Stop recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wen-Cong Lu Division of Endocrinology
- 黃瓊慧 Division of Endocrinology
- 許瑞旭 Division of Endocrinology
- 劉妙真 Division of Endocrinology
- 林承緯 Division of Endocrinology
- 陳正友 Division of Endocrinology
- 王誌慶 Division of Endocrinology
- 陳怡文 Division of Endocrinology
- Jui-Hung Sun Division of Endocrinology
- Jia-Hong Lin Division of Endocrinology
- 洪士淵 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
858 participants